Metabolic ratios of four probes of CYP2D6 in Turkish subjects: A cross-over study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Link
http://link.springer.com/content/pdf/10.1007/BF03189732.pdf
Reference17 articles.
1. Eichelbaum M., Gross A.S. (1990): The genetic polymorphism of debrisoquine sparteine metabolism — clinical aspects. Pharmacol. Ther., 46, 377–394.
2. Horai Y., Ishizaki T., Taga J., Ishikawa K. (1990): Correlation among the metabolic ratios of three test probes (metoprolol, debrisoquine and sparteine) for genetically determined oxidation polymorphism in a Japanese population. Br. J. Clin. Pharmacol., 29, 111–115.
3. Bozkurt A., Basci N.E., Isimer A., Sayal A., Kayaalp S.O. (1994): Polymorphic debrisoquine metabolism in a Turkish population. Clin. Pharmacol. Ther., 55, 399–401.
4. Eichelbaum M., Bertilsson L., Sawe J., Zekorn C. (1982): Polymorphic oxidation as sparteine and debrisoquine: related pharmacogenetic entities. Clin. Pharmacol. Ther., 31, 184–186.
5. McGourthy J.C., Silas J.H., Lennard M.S., Tucker G.T., Woods H.F. (1985): Metoprolol metabolism and debrisoquine oxidation polymorphism-population and family studies. Br. J. Clin. Pharmacol., 20, 555–566.
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nutrimetric Validation of Solanidine as Dietary‐Derived CYP2D6 Activity Marker In Vivo;Clinical Pharmacology & Therapeutics;2023-12-03
2. Physiologically Based Pharmacokinetic Modeling of Metoprolol Enantiomers and α-Hydroxymetoprolol to Describe CYP2D6 Drug-Gene Interactions;Pharmaceutics;2020-12-11
3. Addressing phenoconversion: the Achilles' heel of personalized medicine;British Journal of Clinical Pharmacology;2015-01-20
4. Polymorphismes du CYP2D6 et tamoxifène : perspectives thérapeutiques dans la prise en charge des cancers du sein hormonodépendants;Bulletin du Cancer;2010-03
5. Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping;European Journal of Clinical Pharmacology;2007-02-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3